Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.83M Buy
13,347
+3,668
+38% +$1.26M 0.81% 42
2026
Q1
$3.41M Sell
9,679
-133
-1% -$47.4K 0.84% 40
2025
Q4
$3.21M Buy
+9,812
New +$3.11M 0.74% 46

Other funds holding AMGN

Meiji Yasuda America's AMGN Position: Q2 2026 in Review

Meiji Yasuda America increased its Amgen (AMGN) stake by 38% in Q2 2026, buying an estimated $1.26M and bringing the position to 13,347 shares worth $4.83M. The position accounts for 0.81% of the portfolio, ranked #42.

Meiji Yasuda America first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,145 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Meiji Yasuda America held 13,347 shares of Amgen worth $4.83M as of Q2 2026.
  • Meiji Yasuda America bought 3,668 Amgen shares in Q2 2026, an estimated $1.26M.
  • Amgen made up 0.81% of Meiji Yasuda America's portfolio in Q2 2026, its #42 holding.
  • Meiji Yasuda America first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,145 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Meiji Yasuda America's 13F filing for Q2 2026, filed 28 Jul 2026.